Valmet's Board of Directors has initiated a strategic review to evaluate a potential separation of its two core businesses - Biomaterial Solutions and Services, and Process Performance Solutions - into two standalone publicly listed companies on Nasdaq Helsinki.
The review will assess whether separation would create additional value for shareholders compared with the current combined structure, with both businesses reporting as separate segments that have grown into large, mostly independent profitable operations with strong market positions.
Process Performance Solutions has reached approximately Euro 1.7 billion in annual net sales following the recent completion of the Severn acquisition, while Biomaterial Solutions and Services serves the pulp, board, paper, tissue, and energy industries with a competitive advantage anchored in its installed base and global services penetration.
Process Performance Solutions has evolved into a diversified industrial platform with close to 70% of net sales generated from industries beyond pulp and paper. The Board's initial assessment indicates that separation could allow each business to pursue growth opportunities more independently with sharper management focus, greater agility, tailored capital allocation, and flexible access to external capital.
Pekka Vauramo, Chair of the Board, stated that the Board continuously evaluates how to create the greatest long-term value for shareholders and will only proceed with separation if detailed analysis shows it is clearly in the best interests of shareholders.
Thomas Hinnerskov, President and CEO of Valmet, said both businesses are well positioned with strong customer relationships and market positions, adding that the review reflects the strength and maturity of both businesses built through execution and strategic investments.
The Board will provide an update on the review latest in connection with the publication of full-year 2026 results, with no guarantee that the review will result in any transaction.